STOCK TITAN

Bio-Techne (TECH) insider updates stock holdings

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BIO-TECHNE Corp (symbol: TECH) is the issuer of record for a Form 4 filing submitted to the SEC.

Positive

  • None.

Negative

  • None.
Insider Geist William
Role PRESIDENT, PROTEIN SCIENCES
Type Security Shares Price Value
Grant/Award Restricted Stock Units F5, F10 14,762 $0.00 $0.00
Grant/Award Restricted Stock Units F5, F11 23,985 $0.00 $0.00
holding Stock Options (Right to Buy) F1 -- -- --
holding Stock Options (Right to Buy) F1 -- -- --
holding Stock Options (Right to Buy) F1 -- -- --
holding Stock Options (Right to Buy) F2 -- -- --
holding Stock Options (Right to Buy) F3 -- -- --
holding Stock Options (Right to Buy) F4 -- -- --
holding Performance Restricted Stock Units F5, F6 -- -- --
holding Performance Restricted Stock Units F5, F7 -- -- --
holding Restricted Stock Units F5, F8 -- -- --
holding Restricted Stock Units F5, F9 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 44,596 shares (Direct); Stock Options (Right to Buy) — 123,059 shares (Direct); Performance Restricted Stock Units — 35,093 shares (Direct); Common Stock — 24,943 shares (Direct)
Footnotes (11)
  1. F1. 100% vested.
  2. F2. Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
  3. F3. Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
  4. F4. Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.
  5. F5. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  6. F6. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  7. F7. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  8. F8. 2,623 restricted stock units vest on 8/15/2027.
  9. F9. 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028.
  10. F10. 4,921 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 4,920 restricted stock units vest on 8/17/2029.
  11. F11. 23,985 restricted stock units vest on 8/17/2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Geist William

(Last)(First)(Middle)
614 MCKINLEY PLACE NE

(Street)
MINNEAPOLIS MINNESOTA 55413

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [ TECH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
PRESIDENT, PROTEIN SCIENCES
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock24,943D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$100.39 (1)02/01/2029Common Stock15,91215,912D
Stock Options (Right to Buy)$94.52 (1)08/15/2029Common Stock29,60029,600D
Stock Options (Right to Buy)$84.61 (1)08/15/2030Common Stock1,5261,526D
Stock Options (Right to Buy)$84.61 (2)08/15/2030Common Stock30,05930,059D
Stock Options (Right to Buy)$74.91 (3)08/15/2034Common Stock21,20421,204D
Stock Options (Right to Buy)$53.6 (4)08/15/2035Common Stock24,75824,758D
Performance Restricted Stock Units(5) (6) (6)Common Stock15,73815,738D
Performance Restricted Stock Units(5) (7) (7)Common Stock19,35519,355D
Restricted Stock Units(5) (8) (8)Common Stock2,6232,623D
Restricted Stock Units(5) (9) (9)Common Stock3,2266,452D
Restricted Stock Units(5)08/17/2026A14,762 (10) (10)Common Stock14,762$014,762D
Restricted Stock Units(5)08/17/2026A23,985 (11) (11)Common Stock23,985$023,985D
Explanation of Responses:
1. 100% vested.
2. Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
3. Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
4. Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.
5. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
6. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
7. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
8. 2,623 restricted stock units vest on 8/15/2027.
9. 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028.
10. 4,921 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 4,920 restricted stock units vest on 8/17/2029.
11. 23,985 restricted stock units vest on 8/17/2029.
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed08/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)